» Articles » PMID: 34696508

The Expression Level of HIV-1 Vif Is Optimized by Nucleotide Changes in the Genomic SA1D2prox Region During the Viral Adaptation Process

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2021 Oct 26
PMID 34696508
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

HIV-1 Vif plays an essential role in viral replication by antagonizing anti-viral cellular restriction factors, a family of APOBEC3 proteins. We have previously shown that naturally-occurring single-nucleotide mutations in the SA1D2prox region, which surrounds the splicing acceptor 1 and splicing donor 2 sites of the HIV-1 genome, dramatically alter the Vif expression level, resulting in variants with low or excessive Vif expression. In this study, we investigated how these HIV-1 variants with poor replication ability adapt and evolve under the pressure of APOBEC3 proteins. Adapted clones obtained through adaptation experiments exhibited an altered replication ability and Vif expression level compared to each parental clone. While various mutations were present throughout the viral genome, all replication-competent adapted clones with altered Vif expression levels were found to bear them within SA1D2prox, without exception. Indeed, the mutations identified within SA1D2prox were responsible for changes in the Vif expression levels and altered the splicing pattern. Moreover, for samples collected from HIV-1-infected patients, we showed that the nucleotide sequences of SA1D2prox can be chronologically changed and concomitantly affect the Vif expression levels. Taken together, these results demonstrated the importance of the SA1D2prox nucleotide sequence for modulating the Vif expression level during HIV-1 replication and adaptation.

Citing Articles

Involvement of a Rarely Used Splicing SD2b Site in the Regulation of HIV-1 mRNA Production as Revealed by a Growth-Adaptive Mutation.

Koma T, Doi N, Le B, Kondo T, Ishizue M, Tokaji C Viruses. 2023; 15(12).

PMID: 38140666 PMC: 10747208. DOI: 10.3390/v15122424.


Altered HIV-1 mRNA Splicing Due to Drug-Resistance-Associated Mutations in Exon 2/2b.

Muller L, Moskorz W, Brillen A, Hillebrand F, Ostermann P, Kiel N Int J Mol Sci. 2022; 23(1).

PMID: 35008581 PMC: 8745674. DOI: 10.3390/ijms23010156.

References
1.
Rabi S, Laird G, Durand C, Laskey S, Shan L, Bailey J . Multi-step inhibition explains HIV-1 protease inhibitor pharmacodynamics and resistance. J Clin Invest. 2013; 123(9):3848-60. PMC: 4381280. DOI: 10.1172/JCI67399. View

2.
Lebkowski J, Clancy S, Calos M . Simian virus 40 replication in adenovirus-transformed human cells antagonizes gene expression. Nature. 1985; 317(6033):169-71. DOI: 10.1038/317169a0. View

3.
Jordan-Paiz A, Franco S, Martinez M . Impact of Synonymous Genome Recoding on the HIV Life Cycle. Front Microbiol. 2021; 12:606087. PMC: 8007914. DOI: 10.3389/fmicb.2021.606087. View

4.
Presnyak V, Alhusaini N, Chen Y, Martin S, Morris N, Kline N . Codon optimality is a major determinant of mRNA stability. Cell. 2015; 160(6):1111-24. PMC: 4359748. DOI: 10.1016/j.cell.2015.02.029. View

5.
Kammler S, Otte M, Hauber I, Kjems J, Hauber J, Schaal H . The strength of the HIV-1 3' splice sites affects Rev function. Retrovirology. 2006; 3:89. PMC: 1697824. DOI: 10.1186/1742-4690-3-89. View